Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1520 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Microphyt. (7/11/19). "Press Release: Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being". Baillargues. 2019-07-11
Biophytis S.A.. (7/8/19). "Press Release: Biophytis Announces the Launch of its Public Offering on Nasdaq". Paris & Cambridge, MA. 2019-07-08
Nosopharm S.A.S.. (7/3/19). "Press Release: Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics". Lyon & Hamburg. 2019-07-03
Oncovita S.A.S.. (7/2/19). "Press Release: Oncovita Signs Exclusive Licensing Agreement with Institut Pasteur. Agreement Will Cover Development and Marketing of Oncolytic Virotherapies". Paris. 2019-07-02
Erytech Pharma. (6/24/19). "Press Release: Erytech Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies". Lyon & Cambridge, MA. 2019-06-24
Genfit S.A.. (6/24/19). "Press Release: Genfit and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China". Lille & Cambridge, MA. 2019-06-24
Erytech Pharma. (6/24/19). "Press Release: Erytech Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility". Princeton, NJ, Cambridge, MA & Lyon. 2019-06-24
Sanofi S.A.. (6/21/19). "Press Release: Sanofi and Regeneron Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma". Paris & Tarrytown, NY. 2019-06-21
Sanofi S.A.. (6/18/19). "Press Release: Sanofi and Google to Develop New Healthcare Innovation Lab". Paris. 2019-06-18
Dassault Systèmes S.A.. (6/12/19). "Press Release: Dassault Systèmes and Medidata Solutions to Join Forces to Accelerate the Life Sciences Industry Innovation for Patient-Centric Experience Through End-to-End Collaborative Platform". Vélizy-Villacoublay 2019-06-12
Sanofi S.A.. (6/9/19). "Press Release: Soliqua Phase 3 Results Significantly Lowered Blood Sugar Levels Compared to GLP-1 Receptor Agonist Treatments". Paris. 2019-06-09
Sanofi S.A.. (6/7/19). "Press Release: Paul Hudson to Succeed Olivier Brandicourt as Chief Executive Officer". Paris. 2019-06-07
bioMérieux S.A.. (6/6/19). "Press Release: bioMérieux Increases Its Holding in Hybiome from 54% to 67%". Marcy l’Étoile. 2019-06-06
Yposkesi. (6/5/19). "Press Release: Servier Appoints Yposkesi for Lentiviral Vector GMP-Manufacturing in CAR-T Cell Development Technology". Suresnes & Corbeil-Essonnes. 2019-06-05
Yukin Therapeutics S.A.S.. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis. 2019-06-04
Sanofi S.A.. (6/2/19). "Press Release: Phase 3 Trial of Isatuximab Combination Therapy Showed 40% Reduction in the Risk of Disease Progression or Death for Patients with Relapsed/Refractory Multiple Myeloma". Paris. 2019-06-02
Domain Therapeutics S.A.. (5/28/19). "Press Release: European Venture Capital Firm Seventure Partners Renews Its Support to Domain Therapeutics and Invests €3.5M ($3.9M) to Prepare the Next Growth Phase". Strasbourg. 2019-05-28
Nanobiotix S.A.. (5/28/19). "Press Release: Nanobiotix Announces the Launch of Curadigm. A New Nanotechnology Platform for Healthcare". Paris & Cambridge, MA. 2019-05-28
Sensorion S.A.. (5/27/19). "Press Release: Sensorion Announces the Signature of a Partnership Framework Agreement with Institut Pasteur on Gene Therapy Programs Targeting Hearing Loss". Montpellier. 2019-05-27
DNA Script. (5/16/19). "Press Release: DNA Script Raises $38.5 Million in Series B Financing. Oversubscribed Round Led by LSP". Paris. 2019-05-16
TreeFrog Therapeutics S.A.S.. (5/13/19). "Press Release: TreeFrog Therapeutics Raises over €7M ($7.8M) in Series A Financing Round 6 Months after Incorporation". Bordeaux. 2019-05-13
Sanofi S.A.. (5/7/19). "Press Release: Dupixent (dupilumab) Approved for Severe Asthma by European Commission". Paris & Tarrytown, NY. 2019-05-07
Erytech Pharma. (5/6/19). "Press Release: Erytech Proposes the Appointment of Dr. Jean-Paul Kress as Chairman of the Board of Directors". Lyon. 2019-05-06
Transgene S.A.. (5/2/19). "Press Release: Transgene and AstraZeneca Enter into a Collaboration and Exclusive License Option Agreement for Innovative Invir.IO based Armed Oncolytic Immunotherapies". Strasbourg. 2019-05-02
Iktos. (4/29/19). "Press Release: Iktos Announces Research Collaboration with Janssen to Utilize Iktos’ Artificial Intelligence Technology to Increase Speed & Efficiency of Small Molecule Drug Discovery". Paris. 2019-04-29
Sanofi S.A.. (4/26/19). "Press Release: Sanofi Delivers Strong Q1 2019 Business EPS Growth of 9.4% at CER". Paris. 2019-04-26
bioMérieux S.A.. (4/24/19). "Press Release: bioMérieux – First-Quarter 2019 Business Review". Marcy l’Étoile. 2019-04-24
HalioDx S.A.S.. (4/19/19). "Press Release: HalioDx Signs an Exclusive Agreement with Genecast to Make Immunoscore Available in China". Marseille. 2019-04-19
Genfit S.A.. (4/18/19). "Press Release: Genfit Announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC". Lille & Boston, MA. 2019-04-18
Cerenis Therapeutics S.A.. (4/17/19). "Press Release: Cerenis Therapeutics Has Decided to Terminate the Proposed Merger with H4Orphan Pharma". Toulouse. 2019-04-17
bioMérieux S.A.. (4/15/19). "Press Release: “Global-PPS”, a Survey of Antibiotic Use and Bacterial Resistance in Hospitals Worldwide, Tops the 200,000 Patients". Marcy l’Étoile & Antwerp. 2019-04-15
bioMérieux S.A.. (4/1/19). "Press Release: University of Antwerp, bioMérieux, and Wellcome Trust to Coordinate VALUE-Dx, a European Public-Private Partnership to Fight Antimicrobial Resistance through Diagnostics". Antwerp, London & Marcy l’Eoile. 2019-04-14
Theranexus S.A.. (4/9/19). "Press Release: Theranexus Announces Research Collaboration with IRISA Using Artificial Intelligence Technologies to Enhance Therapeutic Targeting of Neurological Interactions". Lyon. 2019-04-09
Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA. 2019-04-04
Nanobiotix S.A.. (4/2/19). "Press Release: Combination of First-in-Class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in Vivo Models of Lung Cancer". Paris & Cambridge, MA. 2019-04-02
Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris. 2019-03-28
Genfit S.A.. (3/27/19). "Press Release: Genfit Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market". Lille & Cambridge, MA. 2019-03-27
Cerenis Therapeutics S.A.. (3/27/19). "Press Release: Cerenis Therapeutics and H4Orphan Pharma Enter into Exclusive Negotiations to Consider a Strategic Merger". Toulouse. 2019-03-27
Pierre Fabre S.A.. (3/21/19). "Press Release: Institut Curie and Pierre Fabre Strengthen Their Immuno-oncology Partnership". Paris & Castres. 2019-03-21
Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY. 2019-03-20
bioMérieux S.A.. (3/19/19). "Press Release: Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury". Deerfield, IL & Marcy l’Etoile. 2019-03-19
Genfit S.A.. (3/14/19). "Press Release: Genfit Announces Launch of Proposed Global Offering and Nasdaq Listing". Lille & Cambridge, MA. 2019-03-14
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. 2019-03-11
Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris. 2019-03-05
Seventure Partners. (3/1/19). "Press Release: Seventure Partners Life Sciences Corporate Update September 2018 – February 2019". Paris. 2019-03-01
Genfit S.A.. (2/27/19). "Press Release: Genfit Files Registration Statement for Proposed Initial Public Offering in the United States". Lille & Cambridge, MA. 2019-02-27
bioMérieux S.A.. (2/27/19). "Press Release: bioMérieux – 2018 Financial Results". 2019-02-27
DNA Script. (2/27/19). "Press Release: DNA Script Announces World’s First Enzymatic Synthesis of a High-Purity 200-Nucleotide Strand of DNA". Marco Island, FL. 2019-02-27
Ynsect S.A.. (2/21/19). "Press Release: Ÿnsect Raises $125m to Become World Leader in Alternative Protein". Paris & London. 2019-02-21
PX’Therapeutics S.A.. (2/20/19). "Press Release: 2019 – PX’Therapeutics Develops Its Services Offer". 2019-02-20
Seventure Partners. (2/20/19). "Press Release: Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C". Paris. 2019-02-20
France Biotech. (2/19/19). "Press Release: France Biotech Announces Launch of HealthTech Investor Day in Paris on June 25th, 2019". Paris. 2019-02-19
Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. 2019-02-12
bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. 2019-02-07
Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. 2019-02-07
OSE Immunotherapeutics S.A.. (2/7/19). "Press Release: OSE Immunotherapeutics and Servier Announce First Option within Global License Agreement Exercised for further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases". 2019-02-07
Sanofi S.A.. (2/6/19). "Press Release: Sanofi’s Board of Directors Notes the Resignation of Christian Mulliez and Co-opts Christophe Babule as Director". Paris. 2019-02-06
Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2019-02-06
Sanofi S.A.. (2/5/19). "Press Release: Isatuximab Phase 3 Trial Meets Primary Endpoint of Prolonging Progression Free Survival in Patients with Relapsed/Refractory Multiple Myeloma". Paris. 2019-02-05
Sanofi S.A.. (2/4/19). "Press Release: CHMP Recommends Approval of Praluent (alirocumab) to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease". Paris & Tarrytown, NY. 2019-02-04
Sanofi S.A.. (1/30/19). "Press Release: Fexinidazole, the First All-oral Treatment for Sleeping Sickness, Approved in Democratic Republic of Congo". Paris & Geneva. 2019-01-30
Cerenis Therapeutics S.A.. (1/24/19). "Press Release: 2018 Annual Results and Clinical Update". Toulouse & Lakeland, US. 2019-01-24
Pharnext S.A.. (1/23/19). "Press Release: Pharnext Raises €15 Million without Discount". Paris. 2019-01-23
Sanofi S.A.. (1/17/19). "Press Release: FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes". Paris & The Woodlands, TX. 2019-01-17
ImaBiotech S.A.S.. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille. 2019-01-17
ImaBiotech S.A.S.. (1/17/19). "Press Release: Metabrain Research and ImaBiotech Initiate a Strategic Partnership to Offer Cuttingedge Preclinical Research Services in Metabolic Disorders". Lille. 2019-01-17
Carbios S.A.. (1/17/19). "Press Release: Carbios and TWB Receive €7.5 Million Funding to Accelerate the Industrialization of the Biorecycling of PET Plastics and Fibers". Clermont-Ferrand. 2019-01-17
Nanobiotix S.A.. (1/16/19). "Press Release: Nanobiotix Plans to Conduct Registered Public Offering in the United States". Paris & Cambridge, MA. 2019-01-16
Biomunex Pharmaceuticals SASU. (1/15/19). "Press Release: Biomunex Pharmaceuticals Signs a Licensing Agreement with Sanofi for the Development of Bi- and Multi-specific Antibodies". Paris. 2019-01-15
Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. 2019-01-07
Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. 2018-12-21
Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. 2018-12-20
Sanofi S.A.. (12/18/18). "Press Release: Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq". Paris. 2018-12-18
Carmat S.A.. (12/17/18). "Press Release: The European Investment Bank Supports Carmat with €30 Million for the Marketing Process of Its Total Artificial Heart". Paris. 2018-12-17
Valneva S.E.. (12/17/18). "Press Release: Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate". Saint-Herblain. 2018-12-17
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
Polyplus-transfection S.A.. (12/13/18). "Press Release: Polyplus-transfection further Expands Transfection Reagent Portfolio for Cell and Gene Therapy GMP production". Strasbourg. 2018-12-13
Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris. 2018-12-12
Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. 2018-12-06
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. 2018-12-05
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Polyplus-transfection S.A.. (11/29/18). "Press Release: Polyplus-transfection Launches a Powerful Nanotechnology for DNA Transfection Composed of jetOptimus Reagent". 2018-11-29
Carbios S.A.. (11/28/18). "Press Release: Carbios and Kem One Sign a Letter of Intent to Implement a PET Biorecycling Demonstration Plant Operated by Carbios in the French Chemical Valley". Clermont-Ferrand. 2018-11-28
Novadiscovery. (11/22/18). "Press Release: Novadiscovery Welcomes Two New Members to Its Team to Strengthen Its Combined Expertise in Artificial Intelligence and Clinical Medicine". Lyon. 2018-11-22
Stilla Technologies S.A.S.. (11/20/18). "Press Release: Stilla Technologies Completes €16 Million ($18 Million) Series A". Paris. 2018-11-20
Ipsen S.A.. (11/15/18). "Press Release: European Commission Approves Ipsen’s Cabometyx (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib". Paris. 2018-11-15
IntegraGen S.A.. (11/12/18). "Press Release: IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers". Paris. 2018-11-12
Quantum Genomics S.A.. (11/12/18). "Press Release: Quantum Genomics Announces Excellent Topline Results from Phase 2b NEW-HOPE Study Evaluating Firibastat for Arterial Hypertension". Paris & New York, NY. 2018-11-12
bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile. 2018-11-09
Sanofi S.A.. (11/1/18). "Press Release: Sanofi and Denali Therapeutics to Develop Treatments for Neurological and Inflammatory Diseases". Paris. 2018-11-01
Sanofi S.A.. (10/31/18). "Press Release: Sanofi Q3 2018 Performance Confirms Return to Growth". Paris. 2018-10-31
PathoQuest S.A.S.. (10/31/18). "Press Release: PathoQuest Achieves Illumina Propel Certification". 2018-10-31
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. 2018-10-24
Innate Pharma S.A.. (10/23/18). "Press Release: Innate Pharma Strengthens and Expands Its Oncology Development Collaboration with AstraZeneca". Marseille. 2018-10-23
Hybrigenics S.A.. (10/23/18). "Press Release: Clinical Study of Inecalcitol in Acute Myeloid Leukemia Stopped for Futility. The Clinical Development of Inecalcitol Is Discontinued". Paris. 2018-10-23
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px

» top